Revenue for the quarter reached $39.65 billion, up 23.5% from $32.30 billion a year earlier. The figure sits just above the consensus estimate of $39.45 billion, a surprise of roughly 0.5 % and a modest beat that reflects continued premium growth in Humana’s Medicare Advantage portfolio.
GAAP earnings per share were $9.83, falling short of the $10.48 consensus estimate and below the $10.75 estimate cited by some analysts. Adjusted EPS, however, rose to $10.31, beating the consensus range of $10.20–$10.29 by $0.02–$0.11. The adjusted beat is largely attributable to tighter medical cost control and higher premium income, while the GAAP miss reflects the impact of the 2026 Star Ratings headwind on quality‑bonus payments.
The insurance segment’s benefit ratio improved to 89.4% from 87.4% in Q1 2025, a gain that signals better cost management and pricing power in the core Medicare Advantage business. The improvement is driven by disciplined medical cost growth and a favorable mix of high‑margin plans.
Segment‑level data show that CenterWell’s revenue grew 12% to $3.2 billion, supported by the integration of MaxHealth and ongoing expansion of its primary care network. The company’s operating cost ratio for CenterWell rose modestly, reflecting integration expenses, but overall operating margin remained stable due to scale and cost‑control initiatives.
Management reaffirmed its full‑year 2026 adjusted EPS guidance at a minimum of $9.00, while lowering GAAP EPS guidance to at least $8.36 from $8.89. "We are pleased with our first quarter and that is because we are where we expected to be," said President and CEO Jim Rechtin. He added, "We expect to double individual MA margin in 2026 adjusted for Stars," underscoring confidence in the company’s margin‑expansion strategy.
The market reacted to the guidance cut and the Star Ratings headwind, with investors focusing on the lower GAAP guidance and the year‑over‑year decline in adjusted EPS from $11.58 in Q1 2025 to $10.31 in Q1 2026. The headwind is driven by reduced quality‑bonus payments and higher medical costs for newer Medicare Advantage members.
George Renaudin, Insurance Segment President, will retire effective June 29 2026, with Aaron Martin and John Barger assuming expanded roles to support the transition.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.